Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

about

HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production.Redox Paradox: A novel approach to therapeutics-resistant cancer.

P2860

Q46245165-25A28F2A-F29D-488D-A443-8991618B41A2 Q50082485-CF45CDFD-14AF-4968-B04D-72BEF27609E1

P2860

Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

Item

http://www.wikidata.org/entity/Q38777221

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

@en

type

Item

label

Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

@en

prefLabel

Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

@en

P1476

Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

@en

P2093

D Lynn Kirkpatrick

http://www.w3.org/2001/XMLSchema#string

P2860

A drug from poison: how the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered

Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways

Intravenously administered vitamin C as cancer therapy: three cases

Redox Regulation in Cancer Stem Cells

Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide

Mechanism of fenretinide (4-HPR)-induced cell death

Fenretinide corrects newly found ceramide deficiency in cystic fibrosis

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations

The thioredoxin antioxidant system

P304

262-273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ARS.2016.6633

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Garth Powis

P577

2016-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26983373

http://www.w3.org/2001/XMLSchema#string

P932

5312618

http://www.w3.org/2001/XMLSchema#string

Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

about

P2860

P2860

Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932